The IPO Buzz: Apnimed (APMD) Upsizes IPO 20 Percent & Prices IPO at $16 – Top of Range
Apnimed (APMD) took its IPO up a notch: The sleep apnea-focused biotech upsized its IPO to 12 million shares – up from 10 million in the prospectus – and priced its IPO at at $16.00 – the top of its range – to raise $192 million on Thursday night, July 30, 2026. Apnimed increased the […]
July 30, 2026 Read More